Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21220258.
- Also identified by DOI 10.1136/adc.2010.198184.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors describe the case of a 5-year-old girl with recurrent laryngeal papillomatosis (RLP) due to human papillomavirus (HPV) type 11, who required frequent surgical treatment. Complete recovery occurred after HPV vaccination (Gardasil). Confirmed remission of RLP has continued during the 17 months of follow-up since vaccination. The authors conclude that HPV vaccination may represent a new therapeutic option in this situation.
Medical subject headings
- Laryngeal Neoplasms
- Papilloma
- Papillomavirus Vaccines